Immuneering Corporation (IMRX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Immuneering Corporation, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -5.17x | -1.08x | -3.91x | -2.53x | -12.69x | -13.95x |
| P/B Ratio | 1.33x | 1.59x | 2.31x | 1.17x | 2.73x | -10.57x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 403.77x | 204.62x | 102.82x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 50.1% | 44.6% | 44.6% |
| Operating Margin | 0.0% | 0.0% | 0.0% | -16325.8% | -1629.2% | -739.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | -15937.3% | -1612.3% | -737.2% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | -16238.4% | -1621.5% | -735.6% |
| Liquidity | ||||||
| Current Ratio | 17.50x | 5.28x | 11.35x | 13.50x | 27.04x | 16.73x |
| Quick Ratio | 17.50x | 5.28x | 11.35x | 13.50x | 27.04x | 16.73x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.10x | 0.05x | 0.04x | 0.03x | -0.03x |
YoY = year-over-year change. Source: FMP..